Dai B - Search Results

1

Whole-exome sequencing of duodenal adenocarcinoma identifies recurrent Wnt/β-catenin signaling pathway mutations.

Yuan W, Zhang Z, Dai B, Wei Q, Liu J, Liu Y, Liu Y, He L, Zhou D. Yuan W, et al. Among authors: dai b. Cancer. 2016 Jun 1;122(11):1689-96. doi: 10.1002/cncr.29974. Epub 2016 Mar 21. Cancer. 2016. PMID: 26998897 Free article.

2

The association between methylation patterns of DNAH17 and clinicopathological factors in hepatocellular carcinoma.

Fan X, Guo H, Dai B, He L, Zhou D, Lin H. Fan X, et al. Among authors: dai b. Cancer Med. 2019 Jan;8(1):337-350. doi: 10.1002/cam4.1930. Epub 2018 Dec 21. Cancer Med. 2019. PMID: 30575322 Free PMC article.

3

Epigenome-wide DNA methylation profiling of portal vein tumor thrombosis (PVTT) tissues in hepatocellular carcinoma patients.

Fan X, Li Y, Yi X, Chen G, Jin S, Dai Y, Cui B, Dai B, Lin H, Zhou D. Fan X, et al. Among authors: dai b, dai y. Neoplasia. 2020 Nov;22(11):630-643. doi: 10.1016/j.neo.2020.09.007. Epub 2020 Oct 13. Neoplasia. 2020. PMID: 33059309 Free PMC article.

4

Expression Characteristics, Immune Signature, and Prognostic Value of the SOCS Family Identified by Multiomics Integrative Analysis in Liver Cancer.

Dong Z, Dai B, Wu R, Fang K, Sui C, Geng L, Yang J. Dong Z, et al. Among authors: dai b. Cancer Rep (Hoboken). 2024 Sep;7(9):e2161. doi: 10.1002/cnr2.2161. Cancer Rep (Hoboken). 2024. PMID: 39307915 Free PMC article.

5

MicroRNA-147 suppresses human hepatocellular carcinoma proliferation migration and chemosensitivity by inhibiting HOXC6.

Sui CJ, Xu F, Shen WF, Dai BH, Lu JJ, Zhang MF, Yang JM. Sui CJ, et al. Am J Cancer Res. 2016 Dec 1;6(12):2787-2798. eCollection 2016. Am J Cancer Res. 2016. PMID: 28042500 Free PMC article.

6

LncRNA ST8SIA6-AS1 promotes hepatocellular carcinoma cell proliferation and resistance to apoptosis by targeting miR-4656/HDAC11 axis.

Fei Q, Song F, Jiang X, Hong H, Xu X, Jin Z, Zhu X, Dai B, Yang J, Sui C, Xu M. Fei Q, et al. Among authors: dai b. Cancer Cell Int. 2020 Jun 11;20:232. doi: 10.1186/s12935-020-01325-5. eCollection 2020. Cancer Cell Int. 2020. PMID: 32536820 Free PMC article.

7

Adjuvant stereotactic body radiotherapy after marginal resection for hepatocellular carcinoma with microvascular invasion: A randomised controlled trial.

Shi C, Li Y, Geng L, Shen W, Sui C, Dai B, Lu J, Pan M, Yang J. Shi C, et al. Among authors: dai b. Eur J Cancer. 2022 May;166:176-184. doi: 10.1016/j.ejca.2022.02.012. Epub 2022 Mar 15. Eur J Cancer. 2022. PMID: 35303509 Clinical Trial.

8

Response to letter entitled: Re: 'Adjuvant stereotactic body radiotherapy after marginal resection for hepatocellular carcinoma with micro-vascular invasion: A randomized controlled trial'.

Shi C, Li Y, Geng L, Shen W, Sui C, Dai B, Lu J, Pan M, Yang J. Shi C, et al. Among authors: dai b. Eur J Cancer. 2022 Oct;174:313-314. doi: 10.1016/j.ejca.2022.06.022. Epub 2022 Jul 18. Eur J Cancer. 2022. PMID: 35863939 Clinical Trial. No abstract available.

9

Overexpression of miR-218 inhibits hepatocellular carcinoma cell growth through RET.

Sui C, Xu F, Shen W, Geng L, Xie F, Dai B, Lu J, Zhang M, Yang J. Sui C, et al. Among authors: dai b. Tumour Biol. 2015 Mar;36(3):1511-8. doi: 10.1007/s13277-014-2679-1. Epub 2014 Nov 6. Tumour Biol. 2015. PMID: 25374061

10

Bioinformatics profiling identifies seven immune-related risk signatures for hepatocellular carcinoma.

Xue F, Yang L, Dai B, Xue H, Zhang L, Ge R, Sun Y. Xue F, et al. Among authors: dai b. PeerJ. 2020 May 26;8:e8301. doi: 10.7717/peerj.8301. eCollection 2020. PeerJ. 2020. PMID: 32518711 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,945 results

Search Page

Filters